CINRYZE™ is an FDA-approved therapy for patients with hereditary angioedema (HAE, also known as C1 esterase inhibitor deficiency). CINRYZE is a C1 esterase inhibitor that is used to prevent attacks and swelling in teenagers and adults with HAE.
Your resource for educational information about HAE, patient support services, and information about CINRYZE therapy.
One-stop source for answers to questions about insurance, financial assistance, and coordinating care.